Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-03-11
1997-11-04
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540492, C07D24304, A61K 3155
Patent
active
056839995
ABSTRACT:
This invention relates to substituted cyclic ureas and derivatives thereof, including compounds of formula (II): ##STR1## said compounds being useful as inhibitors of HIV protease. The present invention also relates to pharmaceutical compositions comprising such compounds and to method of using these compounds for the treatment HIV infection. The present invention also relates to the use of such compounds in processes for the identification of HIV protease inhibitors and for the inhibition or detection of HIV in a bodily fluid sample.
REFERENCES:
Lam et al., Science (1994) 263:380-384.
Jadhav Prabhakar Kondaji
Ko Soo Sung
Bond Robert T.
Ferguson Blair Q.
The DuPont Merck Pharmaceutical Company
LandOfFree
Cyclic urea HIV protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic urea HIV protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic urea HIV protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1833204